Medical Marijuana, Inc. Announces International Coverage at FDA Public Hearing on Cannabis and CBD Products

by adminAdrianRamirez | Jun 3, 2019 | Press Releases

SAN DIEGO, June 3, 2019 /PRNewswire/ — Medical Marijuana, Inc. (MJNA) (the “Company”), the first-ever publicly traded cannabis company in the United States that launched the world’s first-ever cannabis-derived nutraceutical products, brands and...

Medical Marijuana, Inc. CEO to Present on CBD Safety at Sixth Annual New York Cannabis World Congress; Subsidiary HempMeds® to Exhibit New CBD Products

by adminAdrianRamirez | May 29, 2019 | HempMeds, Press Releases

SAN DIEGO, May 29, 2019 — Medical Marijuana, Inc.(OTC:MJNA) (the “Company”), the first-ever publicly traded cannabis company in the United States that launched the world’s first-ever cannabis-derived nutraceutical products, brands and supply...

Medical Marijuana, Inc. Subsidiary Kannaway® Announces First-Ever Authorization in Bulgaria to Sell Hemp-Derived CBD Products

by adminAdrianRamirez | May 28, 2019 | Kannaway, Press Releases

SAN DIEGO, May 28, 2019 — Medical Marijuana, Inc. (OTC:MJNA) (the “Company”), the first-ever publicly traded cannabis company in the United States that launched the world’s first-ever cannabis-derived nutraceutical products, brands and supply...

Medical Marijuana, Inc. Portfolio Company Kannalife, Inc. Publishes New Research on CBD and Chemotherapy-Induced Peripheral Neuropathy

by adminAdrianRamirez | May 23, 2019 | Kannalife Sciences, Press Releases

SAN DIEGO, May 23, 2019 — Medical Marijuana, Inc. (OTC:MJNA) (the “Company”), the first-ever publicly traded cannabis company in the United States that launched the world’s first-ever cannabis-derived nutraceutical products, brands and supply...

Medical Marijuana, Inc. Reports Over $20.2M in Revenue in Q1 2019, Up 92% Year-Over-Year in Financial Results

by adminAdrianRamirez | May 22, 2019 | Press Releases

SAN DIEGO, May 22, 2019 — Medical Marijuana, Inc. (OTC: MJNA), the first-ever publicly traded cannabis company in the United States, announced today its financial results for the quarter ending March 31, 2019, and provided an overview of recent operational...

Medical Marijuana, Inc. CEO Chosen to Present Oral Comments at FDA’s Public Hearing on Products Containing Cannabis and Cannabis-Derived Compounds

by adminAdrianRamirez | May 21, 2019 | Press Releases

SAN DIEGO, May 21, 2019 — Medical Marijuana, Inc. (OTC:MJNA), the first publicly traded cannabis company in the United States, announced today that the Company’s CEO, Dr. Stuart Titus, has been chosen as one of 65 speakers to present oral comments at...